Grupo para la caracterización molecular de las neoplasias hematológicas
Hospital San Agustin
Avilés, EspañaPublications in collaboration with researchers from Hospital San Agustin (1)
2014
-
Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?
American Journal of Hematology, Vol. 89, Núm. 11, pp. E206-E211